Free Trial

Xeris Biopharma (XERS) Insider Trading & Ownership

Xeris Biopharma logo
$3.06 +0.05 (+1.66%)
(As of 11/20/2024 ET)

Xeris Biopharma (NASDAQ:XERS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.56%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$29,973.45
Number Of
Insiders Selling
(Last 12 Months)
0
Get XERS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

XERS Insider Buying and Selling by Quarter

Xeris Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2024John P SchmidDirectorBuy4,285$2.37$10,155.45  
3/14/2024John P SchmidDirectorBuy4,500$2.16$9,720.00  
11/27/2023Jeffrey W ShermanDirectorBuy5,400$1.87$10,098.00  
(Data available from 1/1/2013 forward)

XERS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Xeris Biopharma includes Jeffrey W Sherman, John P Schmid, John Patrick Shannon Jr, Paul R Edick, and Steven Prestrelski. Learn more on insiders at XERS.

4.56% of Xeris Biopharma stock is owned by insiders. Learn more on XERS's insider holdings.

The following insiders have purchased XERS shares in the last 24 months: Jeffrey W Sherman ($10,098.00), John P Schmid ($29,690.45), John Patrick Shannon Jr ($50,461.16), and Paul R Edick ($23,800.00).

Insiders have purchased a total of 61,454 XERS shares in the last 24 months for a total of $114,049.61 bought.

Xeris Biopharma Key Executives

  • Mr. Paul R. EdickMr. Paul R. Edick (Age 68)
    Chairman & CEO
    Compensation: $1.21M
  • Mr. John P. Shannon (Age 62)
    President & COO
    Compensation: $918.15k
  • Mr. Steven M. Pieper (Age 46)
    Chief Financial Officer
    Compensation: $681.14k
  • Ms. Beth P. Hecht J.D. (Age 60)
    Chief Legal Officer & Corporate Secretary
    Compensation: $695.44k
  • Dr. Kenneth E. Johnson Pharm. D. (Age 61)
    Pharm.D., Senior VP of Global Development & Medical Affairs
    Compensation: $596.97k
  • Ms. Allison Wey
    Senior Vice President of Investor Relations & Corporate Communications
  • Mr. Kevin McCulloch
    Chief Commercial Officer


This page (NASDAQ:XERS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners